NM_001146339.2:c.65T>A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001146339.2(VSTM2B):​c.65T>A​(p.Leu22Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000036 in 1,529,722 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000038 ( 0 hom. )

Consequence

VSTM2B
NM_001146339.2 missense

Scores

2
2
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.00200

Publications

0 publications found
Variant links:
Genes affected
VSTM2B (HGNC:33595): (V-set and transmembrane domain containing 2B) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
VSTM2B-DT (HGNC:27615): (VSTM2B divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24543267).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VSTM2BNM_001146339.2 linkc.65T>A p.Leu22Gln missense_variant Exon 1 of 5 ENST00000335523.8 NP_001139811.1 A6NLU5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VSTM2BENST00000335523.8 linkc.65T>A p.Leu22Gln missense_variant Exon 1 of 5 5 NM_001146339.2 ENSP00000335038.6 A6NLU5

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
151976
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000219
AC:
3
AN:
136722
AF XY:
0.0000136
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000533
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000385
AC:
53
AN:
1377746
Hom.:
0
Cov.:
31
AF XY:
0.0000382
AC XY:
26
AN XY:
680030
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30902
American (AMR)
AF:
0.0000284
AC:
1
AN:
35184
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24964
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35100
South Asian (SAS)
AF:
0.00
AC:
0
AN:
78092
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34790
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.0000465
AC:
50
AN:
1075446
Other (OTH)
AF:
0.0000347
AC:
2
AN:
57624
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
151976
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41420
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67942
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000340

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Dec 20, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.65T>A (p.L22Q) alteration is located in exon 1 (coding exon 1) of the VSTM2B gene. This alteration results from a T to A substitution at nucleotide position 65, causing the leucine (L) at amino acid position 22 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.52
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Benign
0.0084
T
Eigen
Benign
-0.044
Eigen_PC
Benign
0.027
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.60
T
M_CAP
Pathogenic
0.34
D
MetaRNN
Benign
0.25
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.5
L
PhyloP100
0.0020
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
-0.090
N
REVEL
Benign
0.12
Sift
Benign
0.39
T
Sift4G
Benign
0.56
T
Polyphen
0.77
P
Vest4
0.47
MVP
0.31
ClinPred
0.16
T
GERP RS
3.9
Varity_R
0.27
gMVP
0.67
Mutation Taster
=51/49
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1026514636; hg19: chr19-30017555; API